A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
Public ClinicalTrials.gov record NCT04776629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-controlled Proof-of-Activity Study With Orticumab in Subjects With Moderate-to-Severe Psoriasis and Cardiometabolic Risk Factors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this proof-of-activity, phase 2 trial is to evaluate the safety and activity of orticumab in subjects with moderate to severe psoriasis and cardiometabolic risk factors.
Study identification
- NCT ID
- NCT04776629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 77 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2021 (Actual)
- Primary completion
- Nov 11, 2022 (Actual)
- Completion
- Nov 11, 2022 (Actual)
- Last update posted
- May 11, 2026
2021 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CCT- Research at the center for Dermatology and Plastic Surgery | Scottsdale | Arizona | 85260 | — |
| Derm Institute & Skin Care Ctr., Inc. | Santa Monica | California | 90404 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Blue Coast Research Center | Vista | California | 92083 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Las Vegas Clinical Trials | Las Vegas | Nevada | 89030 | — |
| Excel Clinical Research | Las Vegas | Nevada | 89109 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 85260 | — |
| SMS Clinical Research | Mesquite | Texas | 75149 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Center for Clinical Studies, LTD.LLP | Webster | Texas | 77598 | — |
| CCT Research - Springville Dermatology | Springville | Utah | 84663 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04776629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04776629 live on ClinicalTrials.gov.